Founded in 1876, Johns Hopkins University is today home to one of the leading medical enterprises in the United States.  Johns Hopkins Health System and Johns Hopkins University School of Medicine have been at the cutting edge of medical research and technology for more than a century.

Located in Baltimore, Maryland, Johns Hopkins receives patients from around the country and around the world.  The physicians, scientists, health professionals and educators at Johns Hopkins are known internationally for their expertise, innovation and professionalism.

Much of what we take for granted in medicine today – from the rigorous training of physicians and nurses to the emphasis on research and the rapid application of that research to patient care – emerged from innovations made more than a century ago at a brand new medical center in Baltimore, Johns Hopkins.  Indeed, today the very name Johns Hopkins means medicine to a majority of Americans, according to a recent Gallup poll.

Hopkins now uses one overarching name – Johns Hopkins Medicine – to identify its whole medical enterprise. This $4-billion organization unites the physicians and scientists of The Johns Hopkins University School of Medicine with the health professionals and facilities that make up the broad Johns Hopkins Health System

The Demonstration Project

Cardiologists at Johns Hopkins recently teamed with health researchers and experts to conduct a demonstration project to compare the outcomes of patients treated with a life-saving procedure called elective angioplasty at hospitals with cardiac surgery on-site versus hospitals that have off-site cardiac surgery back-up. Currently, regulations in many states allow elective angioplasties to be performed only in hospitals with cardiac surgery back-up. 

Because of advances in medical technology that have made angioplasty safer and a sharp increase in demand for the procedure, the aim of the Johns Hopkins study is to determine what is best for heart patients, and what kind of hospitals should provide angioplasty services and under what conditions

Led by renowned cardiologist Thomas Aversano, M.D., the study is being performed by the Cardiovascular Patient Outcomes Research Team (C-PORT-E).